1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

PhagoMed Biopharma GmbH

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Wien Austria

Primary Industry

Pharmaceuticals

About

Founded in 2017 and based in Wien, Austria, PhagoMed Biopharma GmbH operates as a biotechnology company which focuses on accelerating Phage therapy which can be an alternative to antibiotics.
Current Investors
BioNTech SE, Wieland Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.phagomed.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2017
31 Dec 2018
31 Dec 2019

Unlock the recent years of financials and more for PhagoMed Biopharma GmbH.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.